The Gerstner Family Foundation supports basic and translational biomedical research, access to an excellent education for young people in grades K-12, and organizations that assist people who have suffered temporary setbacks and need a “helping hand” to restore their equilibrium.

News


  • Mayo Clinic and Other Experts Call For Increased Focus On Brain Disease Similar to Alzheimer’s
    May 2, 2019

    Through a collaboration with the University of Kentucky and other institutions, Mayo Clinic researchers helped to establish a name for a degenerative brain disease that afflicts the elderly and mimics features of Alzheimer’s disease. The working group describes "limbic-predominant age-related TDP-43 encephalopathy," or LATE, as an underrecognized risk for public health and calls for an urgent focus on research to improve prevention, diagnosis and treatment of the disease. LATE has been known to clinicians for about a decade, but a common terminology was lacking. The group recommends that LATE testing be performed as part of routine autopsy evaluation in all older patients. No diagnostic tests are available to identify patients with LATE, though an exciting area of research will be the development of biomarkers for brain imaging, with the goal of revealing the disease early in the patient’s progression.

    Read more at mayoclinic.org
View More News

About Us


The Gerstner Family Foundation was founded in 1989 by Louis V. Gerstner, Jr. and his family. The foundation is an expression of Mr. Gerstner’s strong personal commitment to give back to society, which he considers as important a part of his legacy as his exceptional career in business. Most of the foundation’s giving is in New York City, Boston and Palm Beach and their surrounding communities.

Learn More